Skip to main content
Matty Rypto Photo
Mahathir Bayena

Mahathir Bayena

GrafaCrypto Journalist

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.

Articles by Mahathir Bayena

Grafa

FDA extends review of AstraZeneca’s breast cancer drug following advisory panel setback

The U.S. Food and Drug Administration has extended its review period for AstraZeneca's (NASDAQ:AZN) New Drug Application for camizestrant, delaying a final decision on the advanced breast cancer treatment.

Read more: FDA extends review of AstraZeneca’s breast cancer drug following advisory panel setback